source
- FDA advisory panel to consider reclassifying several widely used peptidesAn FDA advisory committee is meeting this week to decide whether it will recommend reclassifying a group of popular peptide products. The discussion comes as the industry watches closely for any sh…
- EU releases AI Act transparency guidelines, impacting healthcare AI developersThe European Commission published new guidelines on Monday to help providers and deployers of AI systems meet the transparency obligations set out in the EU AI Act. The guidance includes examples…